December 1, 2015
French Biophytis appoints new Director of Research
Biophytis has appointed Pierre J. Dilda, PhD, as Director of
Research.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: featured
December 1, 2015
Tuberculosis funding gap threatens elimination goals
Funding for tuberculosis research fell $1.3 billion short of global targets last year, threatening worldwide goals to eliminate the disease between 2030 and 2035, researchers said on Monday.
November 30, 2015
Janssen asks for its Chron’s disease drug Stelara U.S. and EU approval
Janssen Biotech, Inc. and Janssen-Cilag International NV (Janssen) are seeking approval from the U.S. and European authorities for Chron’s disease drug Stelara.
November 30, 2015
PureTech Health launches Scientific Advisory Board
Boston-based PureTech Health plc has launched a Scientific Advisory Board (SAB) of distinguished scientists and physicians, and the expansion of PureTech’s senior team.
November 30, 2015
Cipla launching low-dose Efavirenz 400 mg HIV infection therapy
Cipla launching low-dose Efavirenz 400 mg HIV infection therapy
November 30, 2015
Teva and Takeda are forming a new joint venture to operate generics in Japan
Teva and Takeda are forming a new joint venture to operate in Japan
November 30, 2015
Faron: Clevegen can be used as immunotherapy product
A publication on Clever-1 function related to Faron Pharmaceuticals’ novel cancer immunotherapy antibody Clevegen, was published in journal of the American Association of Immunology.
November 30, 2015
India progresses towards polio-free world
“Ours will be the last generation to see the horror of children paralyzed or killed by polio. I am sure,” said Pr Jacob John, Former Christian Medical College, Vellore, Tamil Nadu, India.
“Maybe we will remember 2015 as the year we took the final step to eradicate this disease forever.”
November 27, 2015
Exclusive: Lazard works with Sanofi on $12.7 billion animal health unit deal – sources
By Pamela Barbaglia, Olivia Oran and Arno Schuetze LONDON/NEW YORK/FRANKFURT (Reuters) – Investment bank Lazard is working with Sanofi’s management…
November 27, 2015
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
Two-decade Pfizer mission pays off for Gueggenheim’s deal king